JP2018526642A5 - - Google Patents

Download PDF

Info

Publication number
JP2018526642A5
JP2018526642A5 JP2018510519A JP2018510519A JP2018526642A5 JP 2018526642 A5 JP2018526642 A5 JP 2018526642A5 JP 2018510519 A JP2018510519 A JP 2018510519A JP 2018510519 A JP2018510519 A JP 2018510519A JP 2018526642 A5 JP2018526642 A5 JP 2018526642A5
Authority
JP
Japan
Prior art keywords
synuclein
alpha
sample
antibody
capture antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018510519A
Other languages
English (en)
Japanese (ja)
Other versions
JP6989927B2 (ja
JP2018526642A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/055088 external-priority patent/WO2017033152A1/en
Publication of JP2018526642A publication Critical patent/JP2018526642A/ja
Publication of JP2018526642A5 publication Critical patent/JP2018526642A5/ja
Priority to JP2021122883A priority Critical patent/JP7244949B2/ja
Application granted granted Critical
Publication of JP6989927B2 publication Critical patent/JP6989927B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018510519A 2015-08-25 2016-08-25 リン酸化アルファ-シヌクレインを検出するための方法 Active JP6989927B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021122883A JP7244949B2 (ja) 2015-08-25 2021-07-28 リン酸化アルファ-シヌクレインを検出するための方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562209800P 2015-08-25 2015-08-25
US62/209,800 2015-08-25
US201662297777P 2016-02-19 2016-02-19
US62/297,777 2016-02-19
PCT/IB2016/055088 WO2017033152A1 (en) 2015-08-25 2016-08-25 Methods for detecting phosphorylated alpha-synuclein

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021122883A Division JP7244949B2 (ja) 2015-08-25 2021-07-28 リン酸化アルファ-シヌクレインを検出するための方法

Publications (3)

Publication Number Publication Date
JP2018526642A JP2018526642A (ja) 2018-09-13
JP2018526642A5 true JP2018526642A5 (cg-RX-API-DMAC7.html) 2019-10-03
JP6989927B2 JP6989927B2 (ja) 2022-02-03

Family

ID=56926235

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018510519A Active JP6989927B2 (ja) 2015-08-25 2016-08-25 リン酸化アルファ-シヌクレインを検出するための方法
JP2021122883A Active JP7244949B2 (ja) 2015-08-25 2021-07-28 リン酸化アルファ-シヌクレインを検出するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021122883A Active JP7244949B2 (ja) 2015-08-25 2021-07-28 リン酸化アルファ-シヌクレインを検出するための方法

Country Status (9)

Country Link
US (3) US10852309B2 (cg-RX-API-DMAC7.html)
EP (1) EP3341725B1 (cg-RX-API-DMAC7.html)
JP (2) JP6989927B2 (cg-RX-API-DMAC7.html)
CA (1) CA2994518C (cg-RX-API-DMAC7.html)
DK (1) DK3341725T3 (cg-RX-API-DMAC7.html)
ES (1) ES2890073T3 (cg-RX-API-DMAC7.html)
HU (1) HUE056054T2 (cg-RX-API-DMAC7.html)
PT (1) PT3341725T (cg-RX-API-DMAC7.html)
WO (1) WO2017033152A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2890073T3 (es) * 2015-08-25 2022-01-17 Prothena Biosciences Ltd Métodos para detectar alfa-sinucleína fosforilada
MX2019005594A (es) 2016-11-15 2019-07-04 H Lundbeck As Agentes, usos y metodos para el tratamiento de la sinucleinopatia.
EP3548074A4 (en) 2016-12-02 2020-07-01 Prothena Biosciences Limited INFRARED ASSAY DETECTING SECONDARY ALPHA-SYNUCLEIN STRUCTURE PROFILES
ES3008133T3 (en) 2016-12-16 2025-03-21 H Lundbeck As Agents, uses and methods
KR102573778B1 (ko) 2017-02-17 2023-08-31 브리스톨-마이어스 스큅 컴퍼니 알파-시뉴클레인에 대한 항체 및 그의 용도
GB201720975D0 (en) 2017-12-15 2018-01-31 Ucb Biopharma Sprl Anti-alpha synuclein antibodies
GB201720970D0 (en) 2017-12-15 2018-01-31 Ucb Biopharma Sprl Antibodies
CN120195406A (zh) * 2017-12-21 2025-06-24 H.隆德贝克有限公司 α-共核蛋白病的测定、方法和治疗
GB201803553D0 (en) 2018-03-06 2018-04-18 Univ Newcastle Detection of pathological protein aggregation
WO2020146497A1 (en) * 2019-01-09 2020-07-16 The Regents Of The University Of California An electrochemiluminescence elisa for ps129-a-synuclein
MX2022006676A (es) * 2019-12-04 2022-07-05 Ac Immune Sa Nuevas moleculas para terapia y diagnostico.
CN112710850A (zh) * 2020-12-29 2021-04-27 苏州百志生物科技有限公司 一种检测人体液中α-突触核蛋白含量的试剂盒
WO2024163454A1 (en) * 2023-01-30 2024-08-08 The Regents Of The University Of California A duplex electrochemiluminescence immunoassay for total α-synuclein and ps129-α-synuclein

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
EP0279582A3 (en) 1987-02-17 1989-10-18 Pharming B.V. Dna sequences to target proteins to the mammary gland for efficient secretion
US5633076A (en) 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
JPH05507700A (ja) 1990-06-01 1993-11-04 カイロン コーポレイション 生物学的活性分子を同定するための組成物及び方法
DK0590058T3 (da) 1991-06-14 2004-03-29 Genentech Inc Humaniseret heregulin-antistof
PT667959E (pt) * 1992-10-26 2003-12-31 Lilly Co Eli Metodos para identificar inibidores da producao do peptido beta-amiloide
US5914241A (en) 1993-01-19 1999-06-22 Biosite Diagnostics, Inc. Assays and kits for detecting analytes in the presence of cross-reacting substances
US5827690A (en) 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
US5965375A (en) 1997-04-04 1999-10-12 Biosite Diagnostics Diagnostic tests and kits for Clostridium difficile
US8506959B2 (en) * 2002-11-01 2013-08-13 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
US20080014194A1 (en) * 2003-10-31 2008-01-17 Elan Pharmaceuticals, Inc. Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
WO2005047860A2 (en) 2003-11-08 2005-05-26 Elan Pharmaceuticals, Inc. Antibodies to alpha-synuclein
US7572640B2 (en) 2004-09-28 2009-08-11 Singulex, Inc. Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
EP2527369A3 (en) * 2007-09-13 2012-12-19 University Of Zurich Prorektorat Forschung Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
DK2732289T3 (en) * 2011-07-13 2018-05-22 Acumen Pharmaceuticals Inc ANTIBODIES, KIT AND IN VITRO METHOD FOR DETECTING BETA AMYLOID OLIGOMERS
ES2890073T3 (es) * 2015-08-25 2022-01-17 Prothena Biosciences Ltd Métodos para detectar alfa-sinucleína fosforilada

Similar Documents

Publication Publication Date Title
JP2018526642A5 (cg-RX-API-DMAC7.html)
JP2016521683A5 (cg-RX-API-DMAC7.html)
JP2019506412A5 (cg-RX-API-DMAC7.html)
PH12018501284A1 (en) Anti-tl1a/anti-tnf-alpha bispecific antigen binding proteins and uses thereof
WO2017087589A3 (en) Pd1 and/or lag3 binders
CN113316591A (zh) Cd73抗体及其制备方法和应用
JP2015531768A5 (cg-RX-API-DMAC7.html)
JP2018023398A5 (cg-RX-API-DMAC7.html)
JP2010511397A5 (cg-RX-API-DMAC7.html)
JP2011500091A5 (cg-RX-API-DMAC7.html)
JP2018536393A5 (cg-RX-API-DMAC7.html)
PH12021550662A1 (en) Antigen-binding molecules capable of binding cd3 and cd137 but not simultaneously
JP2012515160A5 (cg-RX-API-DMAC7.html)
JP2023078174A5 (cg-RX-API-DMAC7.html)
JP2019523651A5 (cg-RX-API-DMAC7.html)
EA201070539A1 (ru) НОВЫЕ АНТИТЕЛА, СПЕЦИФИЧНЫЕ К β-АМИЛОИДНЫМ ПЕПТИДАМ, И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ДИАГНОСТИЧЕСКИХ ИЛИ ЛЕКАРСТВЕННЫХ СРЕДСТВ
JP2015527366A5 (cg-RX-API-DMAC7.html)
JP2015524790A5 (cg-RX-API-DMAC7.html)
JP2018524001A5 (cg-RX-API-DMAC7.html)
JP2020506962A5 (cg-RX-API-DMAC7.html)
RU2014133701A (ru) Способ детекции партнера по связыванию мультиспецифического связывающего агента
JP2015527365A5 (cg-RX-API-DMAC7.html)
WO2008006235A3 (en) Scfv antibodies which pass epithelial and/or endothelial layers
EP4253959A3 (en) Anti-idiotypic antibodies directed to the antigen-binding portion of an bcma-binding molecule
JP2021500376A5 (cg-RX-API-DMAC7.html)